Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging Web ontology language (OWL) and …
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
[PDF][PDF] EXPLORING THE PHARMACOGENOMICS KNOWLEDGE BASE (PHARMGKB) FOR REPOSITIONINGBREAST CANCER DRUGS BY LEVERAGING WEB …
Q ZHU, CUI TAO, F SHEN, CG CHUTE - psb.stanford.edu
Traditional drug development is costly and labor-intensive, and scientists are devoted to
finding an alternative way to facilitate the drug discovery process. Drug repositioning, finding …
finding an alternative way to facilitate the drug discovery process. Drug repositioning, finding …
Exploring the pharmacogenomics knowledge base (pharmgkb) for repositioning breast cancer drugs by leveraging Web ontology language (owl) and cheminformatics …
Q Zhu, C Tao, F Shen… - Pacific Symposium …, 2014 - mayoclinic.elsevierpure.com
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
[HTML][HTML] EXPLORING THE PHARMACOGENOMICS KNOWLEDGE BASE (PHARMGKB) FOR REPOSITIONING BREAST CANCER DRUGS BY LEVERAGING WEB …
Q ZHU, CUI TAO, F SHEN… - Pacific Symposium on …, 2014 - ncbi.nlm.nih.gov
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
Exploring the pharmacogenomics knowledge base (pharmgkb) for repositioning breast cancer drugs by leveraging Web ontology language (owl) and cheminformatics …
Q Zhu, C Tao, F Shen… - Pacific Symposium on …, 2014 - pure.johnshopkins.edu
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
[PDF][PDF] EXPLORING THE PHARMACOGENOMICS KNOWLEDGE BASE (PHARMGKB) FOR REPOSITIONING BREAST CANCER DRUGS BY LEVERAGING WEB …
Q ZHU, CUI TAO, F SHEN, CG CHUTE - Pac Symp Biocomput, 2014 - researchgate.net
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging Web ontology language (OWL) and …
Q Zhu, C Tao, F Shen, CG Chute - Pacific Symposium on …, 2014 - europepmc.org
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging Web ontology language (OWL) and …
Q Zhu, C Tao, F Shen… - Pacific Symposium on …, 2014 - pubmed.ncbi.nlm.nih.gov
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
[PDF][PDF] EXPLORING THE PHARMACOGENOMICS KNOWLEDGE BASE (PHARMGKB) FOR REPOSITIONING BREAST CANCER DRUGS BY LEVERAGING WEB …
Q ZHU, CUI TAO, F SHEN, CG CHUTE - Pac Symp Biocomput, 2014 - researchgate.net
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging Web ontology language (OWL) and …
Q Zhu, C Tao, F Shen, CG Chute - Pacific Symposium on …, 2014 - europepmc.org
Computational drug repositioning leverages computational technology and high volume of
biomedical data to identify new indications for existing drugs. Since it does not require costly …
biomedical data to identify new indications for existing drugs. Since it does not require costly …
